The FDA derives just under half of its yearly funding from pharma user fees, which help support its operations and fund ...

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

While it’s not unusual for certain positions to turn over with a new administration, the number of senior-level FDA staffers ...

Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of ...